Home >> CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 7, Number 5
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets logo Bentham Science Publishers logo

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Click here to see all previous issues.

Publisher: Bentham Science Publishers

Related content
Volume 7, Number 5, November 2008

< previous issue | all issues | next issue >

Articles

Editorial [Hot Topic: Drug Addiction and Brain Targets: From Preclinical Research to Pharmacotherapy (Guest Editor: Shafiqur Rahman)]
pp. 391-392(2)
Author: Rahman, Shafiqur

Role of the Dopamine Transporter in the Action of Psychostimulants, Nicotine, and Other Drugs of Abuse
pp. 393-409(17)
Authors: Zhu, J.; Reith, M. E.A.

Selective Antagonism at Dopamine D3 Receptors as a Target for Drug Addiction Pharmacotherapy: A Review of Preclinical Evidence
pp. 410-421(12)
Author: Heidbreder, Christian

Neuronal Nicotinic Receptors as Brain Targets for Pharmacotherapy of Drug Addiction
pp. 422-441(20)
Authors: Rahman, Shafiqur; Lopez-Hernandez, Gretchen Y.; Corrigall, William A.; Papke, Roger L.

Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction
pp. 442-453(12)
Authors: Shippenberg, T. S.; LeFevour, A.; Chefer, V. I.

Free Content The Role of 5-HT3 Receptors in Drug Abuse and as a Target for Pharmacotherapy
pp. 454-467(14)
Authors: Engleman, E. A.; Rodd, Z. A.; Bell, R. L.; Murphy, J. M.

The Endocannabinoid System: A New Molecular Target for the Treatment of Tobacco Addiction
pp. 468-481(14)
Authors: Scherma, Maria; Fadda, Paola; Foll, Bernard L.; Forget, Benoit; Fratta, Walter; Goldberg, Steven R.; Tanda, Gianluigi

Glutamate: The New Frontier in Pharmacotherapy for Cocaine Addiction
pp. 482-491(10)
Authors: Uys, Joachim D.; LaLumiere, Ryan T.

< previous issue | all issues | next issue >

Marked list

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
^ Back to top
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page